Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate via OptiNose versus placebo in adults with chronic rhinosinusitis
NL-OMON30750Phase 2Not yet recruiting
- Sponsor
- OptiNose
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Fluticasone propionate with Placebo (2 arms). Primary endpoints: Change from baseline to last visit in VAS overall symptom score, Clinician assessment of nasal blockage by nasendoscopy and 6 more. Planned start Mar 2007; status: not yet recruiting.
02
Drugs
fluticasone propionate
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NL-OMON30750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30750.